dr. nancy l. lewis on resistance among gist patients and regorafenib
Published 12 years ago • 91 plays • Length 1:18Download video MP4
Download video MP3
Similar videos
-
1:20
dr. nancy l. lewis on targeted therapies in gastroesophageal cancer
-
1:30
dr. nancy l. lewis discusses the correct trial for regorafenib in metastatic colorectal cancer
-
1:49
dr. george demetri describes the mechanism of action of regorafenib in gist
-
1:02
regorafenib as a treatment for gist (gastrointestinal stromal tumour) patients
-
1:13
dr. fuchs on targeting c-met to treat gastric cancers
-
9:34
regorafenib in colorectal cancer
-
2:30
second- and third-line therapies in colorectal cancer
-
42:05
netwise episode 1 refresh: what you need to know about nets & necs.
-
10:23
eric biegansky gist survivor
-
55:51
understanding gist & desmoid tumors
-
4:08
vital conversations: gastrointestinal stromal tumors gist
-
2:36
liferaft group on gastrointestinal stromal tumors (gists)
-
0:51
rare subtypes of gist dictate outcome
-
0:45
how the gut microbiota can radiosensitize tumors
-
3:36
‘glowing tumors’ might be the next step in detecting cancer
-
1:14:37
immunotherapy and gist
-
12:16
advances in net medicine
-
6:16
nuances in antibody selection: left vs right-sided mcrc
-
0:41
netrf session 4 finding the causes of multifocal intestinal nets
-
6:20
what is gist? | what is gastrointestinal stromal tumor? | dr. anil kamath | healius
-
5:23
what you need to know about colorectal cancer
-
7:05
liquid- vs tissue-based testing in colorectal cancer